Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 9 » Issue 1

Efficacy and safety of olodaterol once daily delivered via Respimat® in patients with GOLD 2–4 COPD: results from two replicate 48-week studies

Total article views   Abstract views HTML views PDF downloads Totals
16,381 Dovepress* 11,022 2,152+ 2,644 13,174
PubMed Central* 0 3,207 1,320 3,207
Totals 11,022 5,359 3,964 16,381
*Since 16 June 2014
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 0 1 5

View citations on PubMed Central and Google Scholar